These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38231291)

  • 21. Gemcitabine treatment enhanced the anti-tumor effect of cytokine induced killer cells by depletion of CD4
    Zhao P; Zhu D; Zhang Z; Han B; Gao D; Wei X; Xie X; Li C; Sun W; Wang Q; Guo Q
    Immunol Lett; 2017 Jan; 181():36-44. PubMed ID: 27867030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.
    Dehno MN; Li Y; Weiher H; Schmidt-Wolf IGH
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Autologous Cytokine-Induced Killer Cells Infusion in Colorectal Cancer Patients: A Prospective Study.
    Peng H; Yao M; Fan H; Song L; Sun J; Zhou Z; Du Y; Lu K; Li T; Yin A; Xu J; Wei S
    Cancer Biother Radiopharm; 2017 Aug; 32(6):221-226. PubMed ID: 28820635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.
    Hoyle C; Bangs CD; Chang P; Kamel O; Mehta B; Negrin RS
    Blood; 1998 Nov; 92(9):3318-27. PubMed ID: 9787169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies.
    Pievani A; Belussi C; Klein C; Rambaldi A; Golay J; Introna M
    Blood; 2011 Jan; 117(2):510-8. PubMed ID: 21048157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved activation toward primary colorectal cancer cells by antigen-specific targeting autologous cytokine-induced killer cells.
    Schlimper C; Hombach AA; Abken H; Schmidt-Wolf IG
    Clin Dev Immunol; 2012; 2012():238924. PubMed ID: 22481963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A CTLA-4 blocking strategy based on Nanoboby in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects.
    Wang W; Wang X; Yang W; Zhong K; He N; Li X; Pang Y; Lu Z; Liu A; Lu X
    BMC Cancer; 2021 Sep; 21(1):1029. PubMed ID: 34525966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer.
    Fayyaz F; Yazdanpanah N; Rezaei N
    Cell Commun Signal; 2022 Mar; 20(1):41. PubMed ID: 35346234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures.
    Bonanno G; Iudicone P; Mariotti A; Procoli A; Pandolfi A; Fioravanti D; Corallo M; Perillo A; Scambia G; Pierelli L; Rutella S
    J Transl Med; 2010 Dec; 8():129. PubMed ID: 21138560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis.
    Li CMY; Tomita Y; Dhakal B; Li R; Li J; Drew P; Price T; Smith E; Maddern GJ; Fenix KA
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37117007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
    Oelsner S; Wagner J; Friede ME; Pfirrmann V; Genßler S; Rettinger E; Buchholz CJ; Pfeifer H; Schubert R; Ottmann OG; Ullrich E; Bader P; Wels WS
    Int J Cancer; 2016 Oct; 139(8):1799-809. PubMed ID: 27253354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells.
    Bremm M; Pfeffermann LM; Cappel C; Katzki V; Erben S; Betz S; Quaiser A; Merker M; Bonig H; Schmidt M; Klingebiel T; Bader P; Huenecke S; Rettinger E
    Front Immunol; 2019; 10():1218. PubMed ID: 31214182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.
    Wang QJ; Wang H; Pan K; Li YQ; Huang LX; Chen SP; He J; Ke ML; Zhao JJ; Li JJ; Sun JC; Liang XT; Ma HQ; Chen YB; Xia JC
    Chin J Cancer; 2010 Jul; 29(7):641-8. PubMed ID: 20591215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway.
    Iudicone P; Fioravanti D; Cicchetti E; Zizzari IG; Pandolfi A; Scocchera R; Fazzina R; Pierelli L
    Hum Immunol; 2016 Dec; 77(12):1239-1247. PubMed ID: 27615504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.
    Lin M; Liang S; Jiang F; Xu J; Zhu W; Qian W; Hu Y; Zhou Z; Chen J; Niu L; Xu K; Lv Y
    Immunol Lett; 2017 Mar; 183():37-43. PubMed ID: 28143792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial.
    Zhao H; Wang Y; Yu J; Wei F; Cao S; Zhang X; Dong N; Li H; Ren X
    Clin Colorectal Cancer; 2016 Sep; 15(3):228-35. PubMed ID: 27052743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro].
    DU Z; Zhao XL; Gao YT; Wu CX; Wang YJ; Zhu ZY; Sun Q; Fang SC
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):759-63. PubMed ID: 19173806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells.
    Liu FR; Bai S; Feng Q; Pan XY; Song SL; Fang H; Cui J; Yang JL
    BMC Cancer; 2018 Nov; 18(1):1087. PubMed ID: 30419845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human interferon-alpha increases the cytotoxic effect of CD56(+) cord blood-derived cytokine-induced killer cells on human B-acute lymphoblastic leukemia cell lines.
    Durrieu L; Gregoire-Gauthier J; Dieng MM; Fontaine F; le Deist F; Haddad E
    Cytotherapy; 2012 Nov; 14(10):1245-57. PubMed ID: 22974386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol.
    Rutella S; Iudicone P; Bonanno G; Fioravanti D; Procoli A; Lavorino C; Foddai ML; Lorusso D; Martinelli E; Vacca M; Ipsevich F; Nuti M; Scambia G; Pierelli L
    Cytotherapy; 2012 Aug; 14(7):841-50. PubMed ID: 22563888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.